|
US6635632B1
(en)
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6958330B1
(en)
|
1998-06-22 |
2005-10-25 |
Elan Pharmaceuticals, Inc. |
Polycyclic α-amino-ε-caprolactams and related compounds
|
|
CA2324475A1
(en)
*
|
1998-06-22 |
1999-12-29 |
Elan Pharmaceuticals, Inc. |
Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6774125B2
(en)
|
1998-06-22 |
2004-08-10 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
AU5204799A
(en)
*
|
1998-06-22 |
2000-01-10 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6552013B1
(en)
|
1998-06-22 |
2003-04-22 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
JP2002518481A
(ja)
*
|
1998-06-22 |
2002-06-25 |
エラン ファーマシューティカルズ，インコーポレイテッド |
β−アミロイドペプチドの放出および／またはその合成を阻害するための化合物
|
|
NZ509241A
(en)
|
1998-08-07 |
2003-08-29 |
Du Pont Pharm Co |
Succinoylamino lactams as inhibitors of alpha-beta protein production
|
|
HRP990246A2
(en)
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
|
AU6278099A
(en)
|
1998-09-30 |
2000-04-17 |
Elan Pharmaceuticals, Inc. |
Biological reagents and methods for determining the mechanism in the generation of beta-amyloid peptide
|
|
JP4615727B2
(ja)
|
1998-12-24 |
2011-01-19 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
Ａβタンパク質生成の阻害剤としてのスクシノイルアミノベンゾジアゼピン
|
|
IL143929A0
(en)
|
1999-01-22 |
2002-04-21 |
Elan Pharm Inc |
Acyl derivatives which treat vla-4 related disorders
|
|
US6503902B2
(en)
|
1999-09-13 |
2003-01-07 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
|
|
US6960576B2
(en)
|
1999-09-13 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
|
|
EP1222176A1
(en)
|
1999-10-08 |
2002-07-17 |
Bristol-Myers Squibb Pharma Company |
AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
|
|
KR20090016517A
(ko)
|
1999-12-23 |
2009-02-13 |
벨루스 헬스 (인터내셔널) 리미티드 |
대뇌 아밀로이드 혈관병증을 조절하는 화합물 및 방법
|
|
US6525044B2
(en)
|
2000-02-17 |
2003-02-25 |
Bristol-Myers Squibb Company |
Succinoylamino carbocycles and heterocycles as inhibitors of a-β protein production
|
|
MXPA02009729A
(es)
|
2000-04-03 |
2003-03-27 |
Bristol Myers Squibb Pharma Co |
Lactamas ciclicas como inhibidores de la produccion de la proteina a-beta.
|
|
AU2001253090A1
(en)
|
2000-04-03 |
2001-10-15 |
Bristol-Myers Squibb Pharma Company |
Cyclic lactams as inhibitors of abeta protein production
|
|
US6632812B2
(en)
|
2000-04-11 |
2003-10-14 |
Dupont Pharmaceuticals Company |
Substituted lactams as inhibitors of Aβ protein production
|
|
AU2001261728A1
(en)
|
2000-05-17 |
2001-11-26 |
Bristol-Myers Squibb Pharma Company |
Use of small molecule radioligands for diagnostic imaging
|
|
CA2379445C
(en)
|
2000-06-01 |
2007-08-21 |
Bristol-Myers Squibb Pharma Company |
Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
TWI312779B
(enExample)
*
|
2000-12-28 |
2009-08-01 |
Daiichi Seiyaku Co |
|
|
CN100396680C
(zh)
*
|
2000-12-28 |
2008-06-25 |
第一制药株式会社 |
极迟抗原-4抑制剂
|
|
US20050159460A1
(en)
*
|
2001-12-04 |
2005-07-21 |
Elan Pharmaceuticals |
Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
|
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
|
WO2004002478A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Elan Pharmaceuticals, Inc. |
Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
|
|
FR2842523A1
(fr)
*
|
2002-07-17 |
2004-01-23 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
|
|
MXPA06000850A
(es)
|
2003-07-24 |
2006-03-30 |
Daiichi Seiyaku Co |
Compuesto de acido ciclohexancarboxilico.
|
|
WO2007041270A1
(en)
|
2005-09-29 |
2007-04-12 |
Elan Pharmaceuticals, Inc. |
Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
ZA200803016B
(en)
|
2005-09-29 |
2009-10-28 |
Elan Pharmaceuticals Inc Wyeth |
Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
KR20080100271A
(ko)
|
2006-02-27 |
2008-11-14 |
엘란 파마슈티칼스, 인크. |
Ｖｌａ-4에 의해 매개되는 백혈구 부착을 억제하는 피리미디닐 술폰아미드 화합물
|